NCT02903511View on ClinicalTrials.gov

Feasibility Study of Metformin Therapy in ADPKD

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

August 17, 2020

Study Completion Date

August 17, 2020

Conditions
Polycystic Kidney, Autosomal Dominant
Interventions
DRUG

Metformin

Monitoring of safety and tolerability

DRUG

Placebo

Monitoring of safety and tolerability

Trial Locations (1)

80045

University of Colorado Denver, Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Colorado, Denver

OTHER

NCT02903511 - Feasibility Study of Metformin Therapy in ADPKD | Biotech Hunter | Biotech Hunter